Copyright
        ©The Author(s) 2023.
    
    
        World J Gastrointest Surg. Mar 27, 2023; 15(3): 307-322
Published online Mar 27, 2023. doi: 10.4240/wjgs.v15.i3.307
Published online Mar 27, 2023. doi: 10.4240/wjgs.v15.i3.307
            Table 1 Acute pancreatitis diagnosis, classification, and indications for surgery
        
    | Criteria | |
| Diagnosis of AP (any two) | Abdominal pain | 
| Serum lipase or amylase anomalies | |
| Characteristic radiological features | |
| Mild AP1 | No OF | 
| Absence of local or systemic complications | |
| Moderately severe AP1 | Transient OF (resolves in < 48 h) | 
| Local or systemic complications without persistent OF | |
| Severe AP1 | Persistent OF | 
| Key indications for surgery | Infected necrosis | 
| Complications of pancreatitis | |
| Fistulas | |
| Pseudocyst | |
| Recurrent AP | |
| Abdominal compartment syndrome | |
| Systemic inflammatory response syndrome | |
| Acute necrotizing cholecystitis or intestinal ischemia | |
| Acute bleeding due to a failed endovascular approach | 
            Table 2 Summary of key surgical recommendations in different guidelines for acute pancreatitis management
        
    | IAP1 (grade A and B)[31] | WSES2 (grade 1A, 1B, or 1C)[4] | AGA (pancreatic necrosis)[33] | 
| Mild AP is not an indication for pancreatic surgery (grade B recommendation) | Routine ERCP is not indicated (1A) | Drainage and/or debridement of pancreatic necrosis is indicated in patients with IPN | 
| IPN in patients with clinical signs and symptoms of sepsis is an indication for intervention (recommendation grade B) | ERCP is indicated in patients with GSAP and cholangitis (1B) | Pancreatic debridement should be avoided in the early, acute period (first two weeks) | 
| Early surgery is not recommended within 14 d after the onset of the disease in patients with necrotic pancreatitis (recommendation grade B) | Clinical deterioration with signs of INP is an indication of intervention (1C) | Percutaneous and transmural ED are both appropriate first-line nonsurgical approaches to the management of patients with WON | 
| Interventional management should favor an organ-preserving approach (grade B recommendation) | As a continuum in a step-up approach after percutaneous/endoscopic procedure (1C) | Percutaneous drainage of pancreatic necrosis should be considered in patients with infected or symptomatic necrotic collections in the early acute period (< 2 wk) | 
| ES is an alternative to cholecystectomy in those who are not fit to undergo surgery (grade B recommendation) | In IPN, percutaneous drainage as the first-line of treatment (1A) | SEMS in the form of LAMS appears superior to plastic stents for endoscopic transmural drainage of necrosis | 
| Minimally invasive surgical strategies result in fewer postoperative new-onset OF (1B) | The use of DEN should be reserved for those patients with limited necrosis and not responding to endoscopic transmural drainage | |
| Laparoscopic cholecystectomy is recommended during index admission in mild GSAP (1A) | Minimally invasive operative approaches to the debridement of IPN are preferred to open approaches | |
| The risk of recurrent pancreatitis is reduced when ERCP and sphincterotomy are performed during index admission (1B) | ||
| Over-resuscitation of patients with early SAP should be avoided; intra-abdominal pressure monitoring is necessary (1C) | A step-up approach consisting of percutaneous drainage or endoscopic transmural drainage, followed by DEN, and then surgical debridement is reasonable | |
| OA should be avoided if other strategies can be used to manage IAH (1C) | ||
| Not to use OA after necrosectomy (1C) | ||
| Not to debride or perform an early necrosectomy if forced to perform an early OA due to ACS (1A) | ||
| For patients with disconnected left pancreatic remnants after acute necrotizing mid-body necrosis, definitive surgical management with distal pancreatectomy can be performed | 
- Citation: Alzerwi N. Surgical management of acute pancreatitis: Historical perspectives, challenges, and current management approaches. World J Gastrointest Surg 2023; 15(3): 307-322
 - URL: https://www.wjgnet.com/1948-9366/full/v15/i3/307.htm
 - DOI: https://dx.doi.org/10.4240/wjgs.v15.i3.307
 
